Gerresheimer specializes in containers and complex devices

  • Gerresheimer

Auto-injectors are one of the more recent productsadded to Gerresheimer’s comprehensive range, when it secured a contract for them from a leading American pharmaceuticals manufacturer. Gerresheimer was chosen as supplier as a result of its special expertise in injection-related products and applications and the scope of services it offers. The auto-injector is composed of fourteen plastic components and three metal parts. The plastic components are produced by Gerresheimer, and then made into two subassemblies for final assembly and filling on the customer’s premises.

Gerresheimer’s range of prefillable syringes is further proof of its injection-related application competence. The syringes are made of glass and used around the world as packaging for pharmaceutical and biotech products. They are the first choice primary packaging material for vaccines and numerous other medications and also used for ophthalmic applications. Gerresheimer’s portfolio also includes ClearJect syringes made of COP (cyclic olefin polymer), a high-performance polymer, for special biopharmaceutical and oncological parenteral drugs.

The MultiShell vial by Gerresheimer proves thatexcellent barrier properties and glass-like transparency can be combined in one single product. It protects its content by way of a sandwich or multilayer structure composed of cyclic olefin polymer plus a polyamide layer as an oxygen barrier. This protects sensitive pharmaceuticals against oxidation and water vapor, and the polyamide oxygen barrier increases their shelf life. Gerresheimer has established a commercial production line and offer 2, 5, 10, 15, 50 and 100 ml vials. The installation of a multifunctional, automated packaging line will enable the packaging of different vials from bulk to ready-to-use.

See also

Gerresheimer is investing in a new plant in Skopje, North Macedonia, for medical plastic systems and syringes

Gerresheimer is investing a mid-double-digit million Euro figure in the new plant in the North Macedonian capital of Skopje, an amount that is already included in the company’s medium-term investment plans. Construction is beginning in the first half of 2019, with completion scheduled for the first half of 2020. It is expected that start of production will take place in the second half of 2020.

  • Elias Bittan
  • Product Info
  • English
  • Created 19 May 2015
  • Modified 14 Sep 2015
  • Hits 1352